Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Hamilton Thorne Ltd. (V:HTL)

Business Focus: Advanced Medical Equipment & Technology

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
See Regulatory Filings on SEDAR
Company Contact
Address: 100 Cummings Ctr Ste 465e
BEVERLY MA 01915-6143
Tel: 1-978-9212050
IR: See website
Key People
Meg D. Spencer
Chairman of the Board
David Wolf
President, Chief Executive Officer, Director, IR Contact Officer
Michael W. Bruns
Chief Financial Officer, Vice President - Finance
Diarmaid H. Douglas-Hamilton
Corporate Secretary, Chief Technology Officer and Senior Vice-President - Research & Development of the Corporation, Director
Thomas Kenny
Vice President - Engineering
Business Overview
Hamilton Thorne Ltd. is engaged in the development, manufacture and sale of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets. The Company offers Clinical lasers, Research lasers and Clinical Sperm Analysis Products. Its Clinical lasers include LYKOS laser and ZILOS-tk laser for applications, such as laser-assisted hatching and embryo biopsy for pre-implantation genetic diagnosis (PGD). Its Research lasers include XYRCOS laser, XYClone laser and Stiletto laser for applications, such as transgenic animal production, stem cell applications and somatic cell nuclear transfer. Its Clinical Sperm Analysis Products include IVOS II Clinical, CEROS II Clinical and Dimensions II Strict Morphology for applications, such as fertility testing, reproductive toxicology, and biological research. It also provides ZANDAIR air purification systems for in-vitro fertilization and pathology.
Financial Overview
For the three months ended 31 March 2020, Hamilton Thorne Ltd revenues increased 36% to $10.4M. Net income totaled $145K vs. loss of $564K. Revenues reflect Outside America segment increase of 72% to $7.9M. Net Income reflects Change in fair value of derivative decrease of 63% to $367K (expense), Interest expense including accretion decrease of 24% to $253K (expense).
Reporting Currency: U.S. Dollars
Enterprise value: $152.11M as of Mar 31, 2020
Annual revenue (TTM): $51.17M as of Mar 31, 2020
EBITDA (TTM): $8.69M as of Mar 31, 2020
Net annual income (TTM): $2.02M as of Mar 31, 2020
Free cash flow (TTM): $5.11M as of Mar 31, 2020
Net Debt Last Fiscal Year: N/A
Shares outstanding: 131,828,768 as of May 25, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization